Original agreements, signed in May 2019, allowed for Genus and BCA to jointly research, develop, register and market the PRRS ...

Genus Plc remains under-appreciated despite a 70% return and recent FDA approval for its gene-editing platform. Learn why Greenwood Investors remains bullish.

Genus is listed in the FTSE All-Share, FTSE 350 Low Yield, FTSE 250, FTSE 350 indices. Genus is listed in the Medicine and Biotech sector. Genus Plc Ord 10p is listed on the London Stock Exchange ...

For centuries, biologists have used taxonomy to sort living things into groups based on appearance, behavior and other perceptions of identity. They have christened plants and animals with binomials ...

(Alliance News) - Genus PLC on Monday said it has successfully formed its Chinese porcine joint venture, seeing the move as the "the best platform" to drive growth at PIC China.